Is Theraclion SA halal to invest in?

According to Musaffa's Shariah screening methodology, Theraclion SA (ALTHE.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Theraclion SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Theraclion SA using these criteria to determine its compliance status.

Can Muslims buy shares of Theraclion SA?

Muslim investors may consider investing in Theraclion SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Theraclion SA classified as NOT HALAL?

Musaffa determines the Shariah status of Theraclion SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Theraclion SA updated?

The Shariah compliance status of Theraclion SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Theraclion SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Theraclion SA?

You can check the latest Shariah compliance status of Theraclion SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Theraclion SA ALTHE.PA

€0.48 €0.00 (0.42%) 1D

Last Updated: May 15, 12:00 AM·XPAR

ALTHE.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 25, 2025

Report Source: 2024 Annual Report

Analyst's Ratings for Theraclion SA (ALTHE.PA)

Based on 9 analysts giving stock ratings to Theraclion SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Theraclion SA. Stock Analysis ALTHE.PA

France Health Care Nano Cap Report: 2024 Annual

Théraclion SA develops, manufactures, and markets oncological medical equipment. The company employs 36 full-time employees The company went IPO on 2014-04-25. The firm is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The firm provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.

Key Statistics of Theraclion SA (ALTHE.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.44€0.49

Today's Open

€0.48

Volume

361.51K

P/E Ratio (TTM)

52 Week Range

€0.28€1.25

Market Cap

28.85M

Avg. Volume

169.73K

Dividend Yield

Financial Metrics & Statements of Theraclion SA (ALTHE.PA)

FAQ's for Theraclion SA (ALTHE.PA)

According to Musaffa’s Shariah screening methodology, Theraclion SA (ALTHE.PA) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.